Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Sales | 605 | 1,035 | 532 | 78 | 0 |
| Cost of Goods | 53 | 148 | 78 | 2 | 0 |
| Gross Profit | 552 | 887 | 454 | 76 | 0 |
| Operating Expenses | 2,691 | 1,531 | 1,217 | 1,061 | 2,509 |
| Operating Income | -2,138 | -644 | -763 | -986 | -2,509 |
| Other Income | -37 | -180 | -17 | 0 | 0 |
| Pre-tax Income | -2,175 | -824 | -780 | -986 | -2,509 |
| Net Income Continuous | -2,175 | -824 | -780 | -986 | -2,509 |
| Net Income | $-2,175 | $-824 | $-780 | $-986 | $-2,509 |
| EPS Basic Total Ops | -0.02 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.01 | -0.01 | N/A |
| EPS Diluted Total Ops | -0.02 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.01 | -0.01 | N/A |
| EBITDA(a) | $-2,021 | $-573 | $-710 | $-973 | $-2,509 |